Subscribe
rich-carey-shutterstock-com
Rich Carey / Shutterstock.com
23 June 2020Big PharmaKatie Cambrook and Ben Millson

SPCs: a deep dive into CJEU case law

The European Supplementary Protection Certificate (SPC) Regulation incentivises pharmaceutical research and development by providing an extension to patent protection to compensate for time lost in obtaining a marketing authorisation (MA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
Europe
Unitary SPC should follow new patent system: EC official
11 June 2020   The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.
Big Pharma
CJEU hands down SPC guidance in Royalty Pharma
30 April 2020   The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.


Editor's picks

Why US patent reform is ‘essential’ for US economic prosperity and security
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

Editor's picks

Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

More on this story

Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
Europe
Unitary SPC should follow new patent system: EC official
11 June 2020   The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.
Big Pharma
CJEU hands down SPC guidance in Royalty Pharma
30 April 2020   The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.

More on this story

Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
Europe
Unitary SPC should follow new patent system: EC official
11 June 2020   The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.
Big Pharma
CJEU hands down SPC guidance in Royalty Pharma
30 April 2020   The Court of Justice of the European Union has handed down its decision in Royalty Pharma, providing highly-anticipated guidance on supplementary protection certificates.

More features

AstraZeneca to appeal invalidated diabetes patent in generics dispute
Commercialising genomic tech in Nigeria
Fed Circ: Generic doesn’t infringe Metacel MS drug
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
In vivo cell therapy: A world beyond ex vivo engineering
Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency
How pharma should prep for the six-bill avalanche from Congress